The 40 evidence-based recommendations touch on everything from patient selection to study choice, radiation safety, clinical team dynamics, procedural techniques, study interpretations and more. 

Beyond readmission, 32.9% of patients with increased pancreatic necrosis volumes required additional invasive interventions.

The alerts resulted in an overall reduction of CT scans—down to 29.8% from 38.6%—and increased PECARN guideline adherence.

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

Patients who received an injection had an infection rate of 2.2% at 4-month follow-up. In comparison, the infection rate for the general population in Massachusetts was 7.5% during the same period.

The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.